Financials
- Market Capitalization 7.33 M
- Employee 4
- Founded 2017
- CEO David P Luci
- Website www.acurxpharma.com
- Headquarter Delaware, United States
- FIGI BBG01184DNJ4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4804 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.36 USD | -2.16% | +5.43% | -13.92% | -40.35% | 7.47 M USD | ||
| 4805 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.11 USD | -0.20% | -10.35% | -14.41% | -32.50% | 7.47 M USD | ||
| 4814 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.62 USD | +1.25% | +9.46% | +15.71% | -34.01% | 7.25 M USD | ||
| 4817 | IMRN Immuron Limited - American Depositary Shares | 1.22 USD | +3.39% | -10.95% | +4.27% | -35.11% | 7.14 M USD |